AU3733100A - Compounds that disrupt mammalian rad51 activity - Google Patents
Compounds that disrupt mammalian rad51 activityInfo
- Publication number
- AU3733100A AU3733100A AU37331/00A AU3733100A AU3733100A AU 3733100 A AU3733100 A AU 3733100A AU 37331/00 A AU37331/00 A AU 37331/00A AU 3733100 A AU3733100 A AU 3733100A AU 3733100 A AU3733100 A AU 3733100A
- Authority
- AU
- Australia
- Prior art keywords
- compounds
- rad51 activity
- mammalian rad51
- disrupt
- disrupt mammalian
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12343899P | 1999-03-09 | 1999-03-09 | |
US60123438 | 1999-03-09 | ||
US12821499P | 1999-04-07 | 1999-04-07 | |
US60128214 | 1999-04-07 | ||
PCT/US2000/006125 WO2000053630A2 (en) | 1999-03-09 | 2000-03-09 | COMPOUNDS THAT DISRUPT MAMMALIAN Rad51 ACTIVITY |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3733100A true AU3733100A (en) | 2000-09-28 |
Family
ID=26821557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU37331/00A Abandoned AU3733100A (en) | 1999-03-09 | 2000-03-09 | Compounds that disrupt mammalian rad51 activity |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3733100A (en) |
WO (1) | WO2000053630A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2909383C (en) | 2012-04-12 | 2020-11-10 | University Of Saskatchewan | Phthalocyanine compounds useful as reca inhibitors and methods of using same |
CN109562138B (en) | 2016-05-27 | 2023-03-21 | 辛赛克斯公司 | Protein interface |
GB2584210B (en) | 2017-11-22 | 2022-03-16 | Synthex Inc | Peptides for inhibiting RAD51 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6037125A (en) * | 1996-11-05 | 2000-03-14 | Lexicon Genetics Incorporated | Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells |
-
2000
- 2000-03-09 WO PCT/US2000/006125 patent/WO2000053630A2/en active Application Filing
- 2000-03-09 AU AU37331/00A patent/AU3733100A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000053630A2 (en) | 2000-09-14 |
WO2000053630A3 (en) | 2001-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5413600A (en) | Compounds | |
AUPP873799A0 (en) | Pyridine compounds | |
AU1995800A (en) | Particle manipulation | |
AU7989400A (en) | Compounds and methods | |
AU3215500A (en) | Compounds and methods | |
AU2678800A (en) | Modified calycins | |
AU1132601A (en) | Feature interactions | |
AU1746401A (en) | Compounds | |
AU6032100A (en) | New compounds | |
AUPQ262599A0 (en) | Gene expression | |
AU3178200A (en) | Genetic analysis | |
AU7318700A (en) | Novel transaldolase gene | |
AU6642900A (en) | Improved materials for mycoculture | |
AU3733100A (en) | Compounds that disrupt mammalian rad51 activity | |
AU4974800A (en) | Eosinophil degranulating conditions | |
AU2207001A (en) | Novel compounds and process | |
AU7279000A (en) | Panel-shaped loudspeaker | |
AU6871900A (en) | Tsg-like gene | |
AU1870000A (en) | Gene therapy-2 | |
AU4755200A (en) | Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives | |
AU4861300A (en) | Oven | |
AU7617200A (en) | Chemical feeder | |
AU6382000A (en) | Genome analysis | |
AU4959100A (en) | Container/surround assemblies | |
AU5119400A (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |